Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury in humans.

Roberts DJ, Jenne CN, Léger C, Kramer AH, Gallagher CN, Todd S, Parney IF, Doig CJ, Yong VW, Kubes P, Zygun DA.

J Neurotrauma. 2013 Oct 15;30(20):1727-36. doi: 10.1089/neu.2012.2842. Epub 2013 Aug 28.

PMID:
23799281
2.

A prospective evaluation of the temporal matrix metalloproteinase response after severe traumatic brain injury in humans.

Roberts DJ, Jenne CN, Léger C, Kramer AH, Gallagher CN, Todd S, Parney IF, Doig CJ, Yong VW, Kubes P, Zygun DA.

J Neurotrauma. 2013 Oct 15;30(20):1717-26. doi: 10.1089/neu.2012.2841. Epub 2013 Sep 6.

PMID:
23725031
3.

The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production.

Helmy A, Carpenter KL, Menon DK, Pickard JD, Hutchinson PJ.

J Cereb Blood Flow Metab. 2011 Feb;31(2):658-70. doi: 10.1038/jcbfm.2010.142. Epub 2010 Aug 18.

4.

Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases.

Vilalta A, Sahuquillo J, Rosell A, Poca MA, Riveiro M, Montaner J.

Intensive Care Med. 2008 Aug;34(8):1384-92. doi: 10.1007/s00134-008-1056-1. Epub 2008 Mar 19.

PMID:
18350273
5.

Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy.

Suehiro E, Fujisawa H, Akimura T, Ishihara H, Kajiwara K, Kato S, Fujii M, Yamashita S, Maekawa T, Suzuki M.

J Neurotrauma. 2004 Dec;21(12):1706-11.

PMID:
15684762
6.

Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.

Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, Hosotubo H, Kieko F, Yamashita T, Tanaka H, Shimazu T, Sugimoto H.

Shock. 2004 Aug;22(2):102-7.

PMID:
15257081
7.

Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia.

Buttram SD, Wisniewski SR, Jackson EK, Adelson PD, Feldman K, Bayir H, Berger RP, Clark RS, Kochanek PM.

J Neurotrauma. 2007 Nov;24(11):1707-17.

PMID:
18001201
8.

The cerebral extracellular release of glycerol, glutamate, and FGF2 is increased in older patients following severe traumatic brain injury.

Mellergård P, Sjögren F, Hillman J.

J Neurotrauma. 2012 Jan 1;29(1):112-8. doi: 10.1089/neu.2010.1732. Epub 2011 Oct 11.

PMID:
21988111
9.

Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury.

Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, Mouri T, Tajima G, Kajino K, Nakae H, Tanaka H, Shimazu T, Sugimoto H.

Shock. 2005 May;23(5):406-10.

PMID:
15834305
10.

In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury.

Frugier T, Morganti-Kossmann MC, O'Reilly D, McLean CA.

J Neurotrauma. 2010 Mar;27(3):497-507. doi: 10.1089/neu.2009.1120.

PMID:
20030565
11.

Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury.

Goodman JC, Van M, Gopinath SP, Robertson CS.

Acta Neurochir Suppl. 2008;102:437-9.

PMID:
19388362
12.

Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1alpha expression.

Ding JY, Kreipke CW, Schafer P, Schafer S, Speirs SL, Rafols JA.

Brain Res. 2009 May 1;1268:125-34. doi: 10.1016/j.brainres.2009.02.060. Epub 2009 Mar 10.

13.

Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury.

Ferreira LC, Regner A, Miotto KD, Moura Sd, Ikuta N, Vargas AE, Chies JA, Simon D.

Brain Inj. 2014;28(10):1311-6. doi: 10.3109/02699052.2014.916818. Epub 2014 May 15.

PMID:
24830571
14.

Matrix metalloproteinase-9 in the ventricular cerebrospinal fluid correlated with the prognosis of traumatic brain injury.

Liu CL, Chen CC, Lee HC, Cho DY.

Turk Neurosurg. 2014;24(3):363-8. doi: 10.5137/1019-5149.JTN.8551-13.0.

15.

Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury.

Zheng K, Li C, Shan X, Liu H, Fan W, Wang Z, Zheng P.

Neurol India. 2013 Nov-Dec;61(6):606-9. doi: 10.4103/0028-3886.125258.

16.

Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra.

Hutchinson PJ, O'Connell MT, Rothwell NJ, Hopkins SJ, Nortje J, Carpenter KL, Timofeev I, Al-Rawi PG, Menon DK, Pickard JD.

J Neurotrauma. 2007 Oct;24(10):1545-57.

PMID:
17970618
17.

Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.

Grossetete M, Phelps J, Arko L, Yonas H, Rosenberg GA.

Neurosurgery. 2009 Oct;65(4):702-8. doi: 10.1227/01.NEU.0000351768.11363.48.

18.

Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature.

Jia F, Pan YH, Mao Q, Liang YM, Jiang JY.

J Neurotrauma. 2010 Jun;27(6):1059-68. doi: 10.1089/neu.2009.1067.

PMID:
20233042
19.

Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome.

Kumar RG, Diamond ML, Boles JA, Berger RP, Tisherman SA, Kochanek PM, Wagner AK.

Brain Behav Immun. 2015 Mar;45:253-62. doi: 10.1016/j.bbi.2014.12.021. Epub 2014 Dec 31.

PMID:
25555531
20.

Cerebral microdialysis of interleukin (IL)-1beta and IL-6: extraction efficiency and production in the acute phase after severe traumatic brain injury in rats.

Folkersma H, Brevé JJ, Tilders FJ, Cherian L, Robertson CS, Vandertop WP.

Acta Neurochir (Wien). 2008 Dec;150(12):1277-84; discussion 1284. doi: 10.1007/s00701-008-0151-y. Epub 2008 Nov 25.

PMID:
19031041
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk